@SanjitSJolly Profile picture

Sanjit Jolly

@SanjitSJolly

Interventional Cardiologist and researcher. Has led multiple large randomized trials in Cardiology.

Joined July 2017
Similar User
Natalia Pinilla photo

@DrNataliaP

Adam Greenbaum photo

@AdamGreenbaumMD

Pradeep Yadav photo

@PradeepYadavMD

Sripal Bangalore photo

@SripalBangalore

Harold Dauerman photo

@HarryDauerman

Francesco Costa photo

@Costa_F_8

Sachin Goel photo

@SachinGoelMD

Stefan Harb photo

@stefan_harb

Prashant Kaul photo

@KaulP

Rodrigo Bagur 🇦🇷🇨🇦 photo

@RodrigoBagur

Sohail Khan MD,MHCM photo

@SKhanMHCM

Taral Patel, MD photo

@cathjockey72

Giora Weisz, MD photo

@Giora_Weisz_MD

Andrew M. Goldsweig, MD, MS photo

@AGoldsweig

Javed Ahmed photo

@jmahmed

Sanjit Jolly Reposted

Happiest Birthday to #PHRI's Founding Executive Director and Senior Scientist, Dr. Salim Yusuf! 🎉 Under his leadership, PHRI has shaped global #healthcare guidelines and practices, positively influencing millions of lives worldwide. phri.ca/salimyusuf/

This leader in #GlobalHealth is celebrating his birthday today! Happy birthday to #CMHFLaureate, Dr. Salim Yusuf ow.ly/Ne0y50Q2Jva



Presented at TCT and now available @PHRIresearch @McMasterU @TCTConference @TCTMD

Original Article: Colchicine in Acute Myocardial Infarction (CLEAR) nej.md/4i2U6dV #Cardiology

NEJM's tweet image. Original Article: Colchicine in Acute Myocardial Infarction (CLEAR) <a style="text-decoration: none;" rel="nofollow" target="_blank" href="https://t.co/k3fRIyyFpd">nej.md/4i2U6dV</a> 

#Cardiology
NEJM's tweet image. Original Article: Colchicine in Acute Myocardial Infarction (CLEAR) <a style="text-decoration: none;" rel="nofollow" target="_blank" href="https://t.co/k3fRIyyFpd">nej.md/4i2U6dV</a> 

#Cardiology


A big thank you to all the CLEAR SYNERGY investigators worldwide @NEJM @PHRIresearch @McMasterU @AHAScience

SanjitSJolly's tweet image. A big thank you to all the CLEAR SYNERGY investigators worldwide @NEJM @PHRIresearch @McMasterU @AHAScience

Sanjit Jolly Reposted

Original Article: Colchicine in Acute Myocardial Infarction (CLEAR) nej.md/4i2U6dV #Cardiology

NEJM's tweet image. Original Article: Colchicine in Acute Myocardial Infarction (CLEAR) <a style="text-decoration: none;" rel="nofollow" target="_blank" href="https://t.co/k3fRIyyFpd">nej.md/4i2U6dV</a> 

#Cardiology
NEJM's tweet image. Original Article: Colchicine in Acute Myocardial Infarction (CLEAR) <a style="text-decoration: none;" rel="nofollow" target="_blank" href="https://t.co/k3fRIyyFpd">nej.md/4i2U6dV</a> 

#Cardiology

Sanjit Jolly Reposted

In the first US trial evaluating a drug-coated balloon for coronary in-stent restenosis, we found that the Agent paclitaxel balloon reduced target lesion failure by > 40% compared with conventional angioplasty. Now FDA approved. Published in JAMA now: jamanetwork.com/journals/jama/…


Enrolled first patient in Canada to STEMI DTU trial! Looking forward to seeing results of trial. @NavinKapur4 @Abiomed @GreggWStone @BillONeillMD


Sanjit Jolly Reposted

The ROTA-CUT trial evaluates the impact of combining rotational atherectomy with cutting balloon angioplasty compared to non-compliant balloon angioplasty for calcified lesions in the context of PCI. No significant difference was found in minimum stent area or procedural safety…

EuroInterventio's tweet image. The ROTA-CUT trial evaluates the impact of combining rotational atherectomy with cutting balloon angioplasty compared to non-compliant balloon angioplasty for calcified lesions in the context of PCI. No significant difference was found in minimum stent area or procedural safety…

Sanjit Jolly Reposted

No-reflow management in STEMI patients undergoing PCI is poorly defined. This core laboratory analysis of the TOTAL trial (n=1,800) shows that while thrombectomy did not reduce no-reflow in all patients, it may have a synergism with direct stenting. eurointervention.pcronline.com/article/no-ref…

DFCapodanno's tweet image. No-reflow management in STEMI patients undergoing PCI is poorly defined. This core laboratory analysis of the TOTAL trial (n=1,800) shows that while thrombectomy did not reduce no-reflow in all patients, it may have a synergism with direct stenting. <a style="text-decoration: none;" rel="nofollow" target="_blank" href="https://t.co/JcGAWhclmG">eurointervention.pcronline.com/article/no-ref…</a>

Novasight hybrid IVUS/OCT, great innovation ⁦@OPCILive

SanjitSJolly's tweet image. Novasight hybrid IVUS/OCT, great innovation ⁦@OPCILive⁩

Women as one with ⁦@Drroxmehran⁩ ⁦@JulieTylerTime⁩ ⁦@OPCILive⁩. Amazing story Roxana!

SanjitSJolly's tweet image. Women as one with ⁦@Drroxmehran⁩ ⁦@JulieTylerTime⁩ ⁦@OPCILive⁩. Amazing story Roxana!

Sanjit Jolly Reposted

#CRT2023 simultaneous publication. In the randomized UNIVERSAL trial, ultrasound-guided femoral access was associated with fewer major bleeding and vascular complications compared to a non-guided strategy especially when a vascular closure device was used. eurointervention.pcronline.com/article/ultras…

DFCapodanno's tweet image. #CRT2023 simultaneous publication. In the randomized UNIVERSAL trial, ultrasound-guided femoral access was associated with fewer major bleeding and vascular complications compared to a non-guided strategy especially when a vascular closure device was used. <a style="text-decoration: none;" rel="nofollow" target="_blank" href="https://t.co/PVX3FYrKO3">eurointervention.pcronline.com/article/ultras…</a>

CRT2023, Chet Rihal @ChetRihal Ron Waksman @ronwaksman Highest attendance ever!

SanjitSJolly's tweet image. CRT2023, Chet Rihal @ChetRihal Ron Waksman @ronwaksman Highest attendance ever!

Sanjit Jolly Reposted

Very grateful for the opportunity to present our UNIVERSAL vascular closure device (VCD) subgroup analysis @CRT_meeting with simultaneous publication in @EuroInterventio US may be particularly helpful when using VCDs! @SanjitSJolly @PHRIresearch @USherbrooke

MA_dEntremont's tweet image. Very grateful for the opportunity to present our UNIVERSAL vascular closure device (VCD) subgroup analysis @CRT_meeting with simultaneous publication in @EuroInterventio US may be particularly helpful when using VCDs! @SanjitSJolly @PHRIresearch @USherbrooke

#CRT2023 simultaneous publication. In the randomized UNIVERSAL trial, ultrasound-guided femoral access was associated with fewer major bleeding and vascular complications compared to a non-guided strategy especially when a vascular closure device was used. eurointervention.pcronline.com/article/ultras…

DFCapodanno's tweet image. #CRT2023 simultaneous publication. In the randomized UNIVERSAL trial, ultrasound-guided femoral access was associated with fewer major bleeding and vascular complications compared to a non-guided strategy especially when a vascular closure device was used. <a style="text-decoration: none;" rel="nofollow" target="_blank" href="https://t.co/PVX3FYrKO3">eurointervention.pcronline.com/article/ultras…</a>


Sanjit Jolly Reposted

Calling all New England IC Fellows: Don’t miss the @SCAI First fellows-focused event on Thursday, January 26, discussing complications and how to manage or avoid potential disasters. ➡️ Register Now: scaipro.scai.org/URL/SFNE-Jan20… ➡️ Submit Your Case: scaipro.scai.org/URL/SFCaseSubm…

mickeylev1's tweet image. Calling all New England IC Fellows: Don’t miss the @SCAI First fellows-focused event on Thursday, January 26, discussing complications and how to manage or avoid potential disasters.

➡️ Register Now: <a style="text-decoration: none;" rel="nofollow" target="_blank" href="https://t.co/JdSO4uvRXm">scaipro.scai.org/URL/SFNE-Jan20…</a>

➡️ Submit Your Case: <a style="text-decoration: none;" rel="nofollow" target="_blank" href="https://t.co/mCxHEmBkDm">scaipro.scai.org/URL/SFCaseSubm…</a>

Pleasure chatting with Matt Cavender and SunMoonKim, Universal trial ACCEL podcast @TCTConference @ACCinTouch @PHRIresearch @MacDeptMed

Listen to a 🆕 episode of #ACCEL Lite where Dr. @SanjitSJolly & Matt Cavender, MD MPH, FACC, with Dr. @SunMoonKimMD, discuss Routine Ultrasound for Vascular Access. 🎧 Tune in here: bit.ly/3sM0QEv #ACCEd

ACCinTouch's tweet image. Listen to a 🆕 episode of #ACCEL Lite where Dr. @SanjitSJolly &amp; Matt Cavender, MD MPH, FACC, with Dr. @SunMoonKimMD, discuss Routine Ultrasound for Vascular Access.

🎧 Tune in here: <a style="text-decoration: none;" rel="nofollow" target="_blank" href="https://t.co/21kJeCii6M">bit.ly/3sM0QEv</a> #ACCEd


Ultrasound Guidance for Vascular Access for Cardiac Procedures: A Randomized Trial (UNIVERSAL) - tctmd.com@CMichaelGibson⁩ ⁦@PHRIresearch⁩ ⁦@TCTConferencetctmd.com/videos/ultraso…


Sanjit Jolly Reposted

The most relevant message from the trial, yes, @SanjitSJolly is very smart!

RodrigoBagur's tweet image. The most relevant message from the trial, yes, @SanjitSJolly is very smart!
RodrigoBagur's tweet image. The most relevant message from the trial, yes, @SanjitSJolly is very smart!
RodrigoBagur's tweet image. The most relevant message from the trial, yes, @SanjitSJolly is very smart!
RodrigoBagur's tweet image. The most relevant message from the trial, yes, @SanjitSJolly is very smart!

Sanjit Jolly Reposted

In the Routine Ultrasound Guidance for Vascular Access for Cardiac Procedures (UNIVERSAL) RCT, ultrasonography did not reduce bleeding or vascular complications for femoral access but did facilitate access. ja.ma/3RRdQ6E @SanjitSJolly @TCTConference


Routine Ultrasonography Guidance for Femoral Vascular Access for Cardiac Procedures: The UNIVERSAL Randomized Clinical Trial | Radiology | JAMA Cardiology | JAMA Network jamanetwork.com/journals/jamac…


Loading...

Something went wrong.


Something went wrong.